Some Merit-Based Incentive Payment System (MIPS) participants have received inaccurate payment adjustments as a result of Medicare Part B drug costs incorrectly being included in the adjustments. The Centers for Medicare & Medicaid Services (CMS) is aware of the error and is working to resolve the issue. ASCO is in contact with CMS and will continue to keep members informed.
ASCO’s QOPI Round 1 of reporting is now open for data abstraction. Round 1 will close on June 3, and final reports will be available approximately two weeks after the round closes. Participants whose practices complete two consecutive rounds of QOPI participation can document their efforts in a new ASCO University course and be awarded 20 ABIM, AMA PRA Category 1, or ANCC credits.
U.S. Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb and ASCO CEO Dr. Clifford Hudis discuss FDA’s role in delivering high-quality cancer care in the latest episode of the ASCO in Action Podcast. The conversation focuses on improving the drug development process, expanded access to investigational treatments, and how FDA is addressing tobacco control.
ASCO Symposia bring together specialists from around the world to offer educational content and the latest scientific discoveries in the respective fields, while providing ample time for networking and collaboration. Upcoming Symposia include the Palliative and Supportive Care in Oncology Symposium, Gastrointestinal Cancers Symposium, Cancer Survivorship Symposium: Advancing Care in Research, Genitourinary Cancers Symposium and more.